NasdaqCM - Nasdaq Real Time Price USD
eXoZymes, Inc. (EXOZ)
12.81
-1.15
(-8.21%)
At close: June 13 at 4:00:00 PM EDT
12.86
+0.05
+(0.39%)
After hours: June 13 at 4:04:15 PM EDT
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EXOZ | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Related Tickers
GNIIF GNI Group Ltd.
12.02
0.00%
PTCHF PureTech Health plc
1.6800
0.00%
SBHMY Sino Biopharmaceutical Limited
9.48
0.00%
SLNCF Silence Therapeutics plc
1.5000
0.00%
OPORF hVIVO plc
0.2400
0.00%
REVBW Revelation Biosciences, Inc.
0.0120
0.00%
GNMSF Genmab A/S
224.30
0.00%
NTRBW Nutriband Inc.
1.9000
-14.80%
SBMFF Sino Biopharmaceutical Limited
0.7290
+15.71%
CYCCP Cyclacel Pharmaceuticals, Inc.
5.60
+2.75%